Simaravibart

Simaravibart (MAD-0004J08) is an IgG1κ antibody targeting the SARS-CoV2 spike (S) glycoprotein receptor binding domain[1].

Product Specifications

CAS Number

[2657609-23-7]

Product Name Alternative

MAD-0004J08

UNSPSC

12352203

Target

SARS-CoV

Type

Inhibitory Antibodies

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/simaravibart.html

Purity

98.59

Solubility

10 mM in DMSO

Smiles

[Simaravibart]

Molecular Weight

(144.955 kDa)

References & Citations

[1]Lim SP. Targeting SARS-CoV-2 and host cell receptor interactions. Antiviral Res. 2023 Feb;210:105514.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 3

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TA351358 100 µL

PSMB8 Rabbit Polyclonal Antibody

Ask

View Details

TL317030 1 Kit

LDOC1 Human shRNA Plasmid Kit (Locus ID 23641)

Ask

View Details

NBL1-08722 0.1 mg

Calpastatin Overexpression Lysate (Native) - (Dry Ice)

Ask

View Details

RG204843 10 µg

PAR6 (PARD6A) (NM_001037281) Human Tagged ORF Clone

Ask

View Details

244466-HRP 100 µL

CDC42EP3 (CDC42 Effector Protein (Rho GTPase Binding) 3, BORG2, CEP3, FLJ46903, UB1) (HRP)

Ask

View Details

PH35025M5 20 µg

Nucleolin (NCL) (NM_005381) Human Recombinant Protein

Ask

View Details